EFFICIENCY OF ADJUVANT XELOX CHEMOTHERAPY FOR PATIENTS WITH RESECTABLE GASTRIC IN RUSSIA (SINGLE INSTITUTION RETROSPECTIVE STUDY)

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2019-65-2-256-262

Published 01.02.2019

Ivan Stilidi⁺⁻
Sergey Nered⁺⁻
Aleksey Kalinin⁺⁻
Olesya Rossomakhina⁺⁻
Anton Barchuk⁺⁻

Ivan Stilidi

Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation

Sergey Nered

Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation

Aleksey Kalinin

Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation

Olesya Rossomakhina

State Institution “St. Luka Lugansk State Medical University “

Anton Barchuk

"Federal State Budgetary Institution «N.N. Petrov National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation

##article.numberofdownloads## 407

##article.numberofviews## 1085

PDF (Русский)

Keywords

XELOX
ADJUVANT CHEMOTHERAPY
GASTRIC CANCER
SUBTOTAL GASTRECTOMY
TOTAL GASTRECTOMY

How to Cite

Stilidi, I., Nered, S., Kalinin, A., Rossomakhina, O., & Barchuk, A. (2019). EFFICIENCY OF ADJUVANT XELOX CHEMOTHERAPY FOR PATIENTS WITH RESECTABLE GASTRIC IN RUSSIA (SINGLE INSTITUTION RETROSPECTIVE STUDY). Voprosy Onkologii, 65(2), 256–262. https://doi.org/10.37469/0507-3758-2019-65-2-256-262

Abstract

Introduction. The effectiveness of the Asian regimen of adjuvant chemotherapy in patients with gastric cancer in the European population remains unclear. The aim of our study was a retrospective assessment of adjuvant chemotherapy (XELOX regimen) after radical surgery (R0) on overall survival. Methods. Database of pts with resectable gastric cancer with stage >pT3 and/or pN+ and M0, who were operated (R0) at single oncological institution during 2007-2017 was reviewed. In univariate and multivariate analyzes were included demographic characteristics, type of tumor according to Lauren, stage, type of treatment and others. Results. 396 pts were identified and 286 were available for analysis.106 (37%) pts received at least one cycle of adjuvant chemotherapy. In univariate analysis, 5OS rate was 64% [95% Cl, 52-80] и 56% [95% Cl, 48-64; p=0,21] in patients received adjuvant chemotherapy and only surgical treatment. After stratifying patients depending on the regional lymph nodes metastasis, 5OS rate in pts with pN1-3 was 69% [95% CI, 57-85] vs 47% [95% CI, 39-58; p = 0,01], respectively...

https://doi.org/10.37469/0507-3758-2019-65-2-256-262

##article.numberofdownloads## 407

##article.numberofviews## 1085

PDF (Русский)

References

Davis P.A., Sano Т. The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions? // Crit. Rev. Oncol. Hematol. -2001. - Vol. 40. - P 77-94. - DOI: 10.1016/S1040-8428(00)00131-1

Strong V.E., Song K.Y, Park C.H. et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram // Ann. Surg. - 2010. - Vol. 251(4). - P. 640-646. - DOI: 10.1097/SLA.0b013e3181d3d29b

Wang J., Sun Y, Bertagnolli M.M. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database // Ann. Surg. Oncol. - 2015. - Vol. 22(9). - P 2965-2971. - DOI: 10.1245/s10434-015-4388-4

Cunningham D., Allum W.H., Stenning S.P, Thompson J.N. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer // N. Engl. J. Med. - 2006. - Vol. 355. - P 11-20. - DOI: 10.1056/NEJMoa055531

Ychou M., Boige V., Pignon J-P, Conroy T. et al. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial // J. Clin. Oncol. - 2011. - Vol. 29(13). - P 1715-1721. - DOI: 10.1200/JC0.2010.33.0597

Al-Batran S.E., Pauligk C., Homann N. et al. LBA-008Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FL0T4 trial (German Gastric Group at AIO) // Ann. Oncol. - 2017. - Vol. 28 (1). - DOI: 10.1093/annonc/mdx302.007

Bang Y.J., Kim Y.W.,Yang H.K. et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial // Lancet. - 2012. - Vol. 379(9813). - P 315321. - DOI: 10.1016/S0140-6736(11)61873-4

Sasako M., Sakuramoto S., Katai H. et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer // J. Clin. Oncol. - 2011. - Vol. 29(33). - P 4387-4393. - DOI: 10.1200/JCO.2011.36.5908

Noh S.H., Park S.R., Yang H.K. et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (Classic): 5-year follow-up of an open-label, randomised phase 3 trial // Lancet oncol. - 2014. - Vol. 15(12). - P 1389-1396. - DOI: 10.1016/S1470-2045(14)70473-5

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Anton Barchuk, A. Atroshchenko, V. Gaydukov, P. Vinogradov, Sergey Tarakanov, Sergey Kanaev, Andrey Arsenev, Yuriy Komarov, Mikhail Kharitonov, Aleksey Barchuk, Vakhtang Merabishvili, Vladimir Kuznetsov, Vladimir Trofimov, Nataliya Gusarova, Igor Kotsyuba, Aleksey Belyaev, Maksim Podolskiy, A. Nefedova, AUTOMATED DIAGNOSIS IN A POPULATION-BASED SCREENING FOR LUNG CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)
Andrey Arseniev , Sergey Novikov, Sergey Kanaev , Evgeny Arseniev, Sergey Tarkov, Anton Barchuk, Yulia Melnik, Andrey Nefedov, Roman Novikov, Anton Zozulya, Nikolay Aristidov, Filipp Antipov, Yuriy Merezhko, Nikolay Ilyin, Zhanna Bryantseva, Irina Akulova , The Non-Targeted Abscopal Effect in High Dose-Rate Radiobiology , Voprosy onkologii : Vol. 69 No. 4 (2023)
Anton Barchuk, K. Gagua, S. Tarkov, A. Nefedova, Andrey Nefedov, Aleksandr Shcherbakov, Aleksey Barchuk, Sergey Kanaev, Viktor Gombolevskiy, Aleksey Belyaev, Andrey Arsenev, K. Kostitsyn, THE EFFECTIVENESS OF SCREENING FOR CANCER , Voprosy onkologii : Vol. 63 No. 4 (2017)
Andrei Аrseniev, Sergei Kanaev, Sergei Novikov, Anton Barchuk , Olga Ponomareva , Philip Antipov , Yuri Merezhko , Anton Zozulya , Yulia Melnik , Andrey Nefedov , Sergey Tarkov , Nikolay Aristidov , Stereotactic radiation therapy in the treatment of primary and metastatic tumor lesions of the spine , Voprosy onkologii : Vol. 68 No. 4 (2022)
Andrey Arsenev, A. Zagryadskikh, V. Gelfond, K. Gagua, K. Kostitsyn, S. Tarkov, Sergey Kanaev, Anton Barchuk, Andrey Nefedov, A. Nefedova, SINGLE-PORT VIDEO-ASSISTED THORACOSCOPIC LOBECTOMIES IN SURGICAL TREATMENT FOR LUNG CANCER , Voprosy onkologii : Vol. 63 No. 3 (2017)
Andrey Arseniev, Sergey Novikov, Sergey Kanaev, Anton Barchuk, Filipp Antipov, Anton Zozulya, Yuliya Melnik, Ketevan Gagua, Andrey Nefedov, Sergey Tarkov, Nikolay Aristidov, Perspectives of stereotactic radiotherapy in primary and oligo-metastatic pulmonary tumors , Voprosy onkologii : Vol. 67 No. 3 (2021)
Давид Заридзе, Dmitry Maksimovich, Ivan Stilidi, A new paradigm of screening and early diagnosis: assessment of benefits and harms , Voprosy onkologii : Vol. 66 No. 6 (2020)
Anton Barchuk, V. Satikov, V. Gaydukov, Antonina Chernaya, Sergey Kanaev, Sergey Tarakanov, Yuriy Komarov, Vladimir Kuznetsov, Andrey Arsenev, Aleksey Belyaev, A. Nefedova, THE USE OF ONTOLOGY IN SCREENING FOR CANCER , Voprosy onkologii : Vol. 63 No. 2 (2017)
Andrey Arseniev, Andrey Nefedov, Aleksey Barchuk, Sergey Novikov, Anton Barchuk, Sergey Tarkov, Sergey Kanaev, Kirill Kosticyn , Alina Nefedova, Ketevan Gagua, Nikolay Aristidov, Treatment algorithms for malignancies accompanied by pleural effusion , Voprosy onkologii : Vol. 67 No. 2 (2021)
Andrey Arsenev, Sergey Novikov, Sergey Kanaev, Anton Barchuk, Andrey Nefedov, F. Antipov, A. Nefedova, S. Tarkov, STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON-SMALL CELL LUNG CANCER , Voprosy onkologii : Vol. 64 No. 5 (2018)

<< < 1 2 3 > >>